Literature DB >> 26892631

Double- and triple-hit lymphomas can present with features suggestive of immaturity, including TdT expression, and create diagnostic challenges.

Laura Moench1, Zohar Sachs2, Garth Aasen1, Michelle Dolan1, Vanessa Dayton1, Elizabeth L Courville1.   

Abstract

Double- and triple-hit lymphomas (DHL/THL) are aggressive B-cell neoplasms characterized by translocation of MYC with concurrent BCL2 and/or BCL6 translocation. In this retrospective study from one institution, we report clinicopathologic features of 13 cases (9 DHL/4 THL). The median age was 59 years (range 30-74) and patients included eight females and five males. Presentation included enlarging lymphadenopathy/masses (11 patients) and abnormal peripheral blood findings (2 patients). Features which raised the differential of an immature neoplasm included terminal deoxynucleotidyl transferase positivity (four cases, two THL/two DHL); dim CD45 expression (seven cases), lack of CD20 (two cases), or lack of surface immunoglobulin light chain (three cases) by flow cytometry; and blastoid morphology (two cases). We conclude that expression of TdT in a B-cell lymphoma with mature features or expression of surface light chain in a case otherwise suggestive of B-lymphoblastic leukemia/lymphoma should prompt an expedited evaluation for DHL/THL.

Entities:  

Keywords:  B lymphoblastic leukemia/lymphoma; B-cell lymphoma unclassifiable; diffuse large B-cell lymphoma; double-hit lymphoma; triple-hit lymphoma

Mesh:

Substances:

Year:  2016        PMID: 26892631      PMCID: PMC6292197          DOI: 10.3109/10428194.2016.1143939

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  36 in total

1.  Precursor B-lymphoblastic transformation of grade I follicle center lymphoma.

Authors:  S H Kroft; R Domiati-Saad; W G Finn; D B Dawson; B Schnitzer; T P Singleton; C W Ross
Journal:  Am J Clin Pathol       Date:  2000-03       Impact factor: 2.493

2.  B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

Authors:  Matija Snuderl; Olga K Kolman; Yi-Bin Chen; Jessie J Hsu; Adam M Ackerman; Paola Dal Cin; Judith A Ferry; Nancy Lee Harris; Robert P Hasserjian; Lawrence R Zukerberg; Jeremy S Abramson; Ephraim P Hochberg; Hang Lee; Alfred I Lee; Christiana E Toomey; Aliyah R Sohani
Journal:  Am J Surg Pathol       Date:  2010-03       Impact factor: 6.394

Review 3.  MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.

Authors:  Adam M Petrich; Chadi Nabhan; Sonali M Smith
Journal:  Cancer       Date:  2014-07-24       Impact factor: 6.860

4.  Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma.

Authors:  Sietse M Aukema; Markus Kreuz; Christian W Kohler; Maciej Rosolowski; Dirk Hasenclever; Michael Hummel; Ralf Küppers; Dido Lenze; German Ott; Christiane Pott; Julia Richter; Andreas Rosenwald; Monika Szczepanowski; Carsten Schwaenen; Harald Stein; Heiko Trautmann; Swen Wessendorf; Lorenz Trümper; Markus Loeffler; Rainer Spang; Philip M Kluin; Wolfram Klapper; Reiner Siebert
Journal:  Haematologica       Date:  2013-10-31       Impact factor: 9.941

5.  The unique immunophenotype of double-hit lymphomas.

Authors:  Alexandra M Harrington; Horatiu Olteanu; Steven H Kroft; Camellia Eshoa
Journal:  Am J Clin Pathol       Date:  2011-04       Impact factor: 2.493

6.  Double hit, triple hit--look for it.

Authors:  Rudolf Benz; Joelle Tchinda
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

7.  Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma.

Authors:  D De Jong; B M Voetdijk; G C Beverstock; G J van Ommen; R Willemze; P M Kluin
Journal:  N Engl J Med       Date:  1988-05-26       Impact factor: 91.245

8.  Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies.

Authors:  A Karsan; R D Gascoyne; R W Coupland; J D Shepherd; G L Phillips; D E Horsman
Journal:  Leuk Lymphoma       Date:  1993-08

9.  MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma.

Authors:  Heike Horn; Marita Ziepert; Claudia Becher; Thomas F E Barth; Heinz-Wolfram Bernd; Alfred C Feller; Wolfram Klapper; Michael Hummel; Harald Stein; Martin-Leo Hansmann; Christopher Schmelter; Peter Möller; Sergio Cogliatti; Michael Pfreundschuh; Norbert Schmitz; Lorenz Trümper; Reiner Siebert; Markus Loeffler; Andreas Rosenwald; German Ott
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

10.  Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas.

Authors:  Raju K Pillai; Malini Sathanoori; Stephen Branden Van Oss; Steven H Swerdlow
Journal:  Am J Surg Pathol       Date:  2013-03       Impact factor: 6.394

View more
  9 in total

Review 1.  The clinicopathologic spectrum of mature aggressive B cell lymphomas.

Authors:  Lisa Rimsza; Stefania Pittaluga; Stephan Dirnhofer; Christiane Copie-Bergman; Laurence de Leval; Fabio Facchetti; Stefano Pileri; Andreas Rosenwald; Andrew Wotherspoon; Falko Fend
Journal:  Virchows Arch       Date:  2017-08-26       Impact factor: 4.064

Review 2.  Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma.

Authors:  Rebecca L King; Eric D Hsi; Wing C Chan; Miguel A Piris; James R Cook; David W Scott; Steven H Swerdlow
Journal:  Virchows Arch       Date:  2022-09-03       Impact factor: 4.535

Review 3.  New developments in the pathology of malignant lymphoma. A review of the literature published from January-April 2016.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2016-06-13       Impact factor: 0.196

4.  Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report.

Authors:  Antonin Bouroumeau; Eleonore Kaphan; Clémentine Legrand; Tatiana Raskovalova; Gautier Szymanski; Claire Vettier; Christine Lefebvre; Marie-Christine Jacob; Anne McLeer; Michel Peuchmaur; Rémy Gressin; Hervé Sartelet
Journal:  J Med Case Rep       Date:  2020-07-27

Review 5.  Double-Hit Lymphoma (MYC and BCL6) with Involvement of Skull and Adnexal Lesions: A Case Report and a Review of the Literature.

Authors:  Hamza Minhas; Cherif Abdelmalek; Marium Khan; James E O'Donnell; Vladimir Gotlieb; Jen Chin Wang
Journal:  Am J Case Rep       Date:  2018-08-30

6.  TdT Positive Lymphoma with MYC, BCL2 and BCL6 Rearrangements: A Review of Diagnosis and Treatment.

Authors:  Aditi Singh; Ishaq Asghar; Laura Kohler; Daniel Snower; Hosam Hakim; Daniel Lebovic
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-03-01       Impact factor: 2.576

7.  High-Grade B-Cell Neoplasm with Surface Light Chain Restriction and Tdt Coexpression Evolved in a MYC-Rearranged Diffuse Large B-Cell Lymphoma: A Dilemma in Classification.

Authors:  Dina Sameh Soliman; Ahmad Al-Sabbagh; Feryal Ibrahim; Ruba Y Taha; Zafar Nawaz; Sarah Elkourashy; Abdulrazzaq Haider; Susanna Akiki; Mohamed Yassin
Journal:  Case Rep Hematol       Date:  2017-08-13

8.  "Double hit" B-lymphoblastic lymphoma with concurrent IGH/BCL2 and 8q24/MYC translocations: a case report.

Authors:  Lu He; Zhiwen Li; Xiangshan Fan; Jieyu Chen; Hongyan Wu; Yao Fu
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

9.  De novo acute lymphoblastic leukemia-like disease of high grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements: a case report and literature review.

Authors:  Akiko Uchida; Yasushi Isobe; Yu Uemura; Yuji Nishio; Hirotaka Sakai; Masayuki Kato; Kaori Otsubo; Masahiro Hoshikawa; Masayuki Takagi; Ikuo Miura
Journal:  BMC Clin Pathol       Date:  2017-11-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.